Ingredients: Water, Butylene Glycol, Glycerin, Glutathione (50.000Ppm), 1,2-Hexanediol, Niacinamide, Tranexamic Acid, Cysteine, Glycine, Tocopherol, Betaine, Panthenol, Carnitine, Ethylhexylglycerin, Sodium Citrate, Citric Acid, Hydrogenated Lecithin, Cholesterol, Dipotassium Glycyrrhizate, Sodium Cocoyl Isethionate, Xanthan Gum
As seen from three RCTs where the intervention was at least one gram of L-carnitine per day, there was a mean drop of 11.41 in fasting blood sugar level (p-value of less than 0.0001)
Basic six therapeutic principles of IEM include: (1) substrate reduction therapy (as in PKU), (2) removal of toxic metabolites (e.g., urea cycle disorders), (3) product supplementation (e.g., cerebral creatine deficiency disorders), (4) stimulating of deficient enzyme activity (e.g., B 6 supplementation in CBS deficiency), (5) enzyme replacement therapy (e.g., in LINCL) or 6) organ transplantation (in some cases of UCD and AIP)